This bill amends Chapter 3, Title 41 of the Idaho Code by adding a new section, 41-351, which establishes reporting requirements for entities participating in the federal 340B drug pricing program. Under this new provision, 340B covered entities must report specific information annually to the state department of health and welfare, the state controller's office, and the attorney general. The required data includes the name of the entity, aggregate acquisition costs for drugs, payments received for dispensed drugs, payments made to pharmacies, the number of claims, and how savings from the program are utilized, particularly for charity care or community benefits. The reports must be categorized by payer type, including commercial, Medicaid, and Medicare.

Additionally, the bill stipulates that the submitted data will be confidential and not available for public inspection. The state controller's office is tasked with aggregating this data and submitting a report to the legislative council by November 15 each year, which will also be made available on the transparent Idaho website. The attorney general is authorized to use the information for investigating Medicaid fraud and ensuring compliance with relevant health administration requirements. The bill declares an emergency, making it effective from July 1, 2025.